You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

METHSCOPOLAMINE BROMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Methscopolamine Bromide patents expire, and when can generic versions of Methscopolamine Bromide launch?

Methscopolamine Bromide is a drug marketed by Aace Pharms, Bayshore Pharms Llc, Breckenridge Pharm, Chartwell Rx, and Pvt Form. and is included in five NDAs.

The generic ingredient in METHSCOPOLAMINE BROMIDE is methscopolamine bromide. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Methscopolamine Bromide

A generic version of METHSCOPOLAMINE BROMIDE was approved as methscopolamine bromide by BRECKENRIDGE PHARM on December 6th, 2011.

  Try a Trial

US Patents and Regulatory Information for METHSCOPOLAMINE BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aace Pharms METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 216786-001 Feb 1, 2024 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 040624-001 Dec 28, 2006 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bayshore Pharms Llc METHSCOPOLAMINE BROMIDE methscopolamine bromide TABLET;ORAL 200602-002 Sep 24, 2012 AA RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.